AbbVie added an independent director and a board seat. The filing also says he will receive director pay, but reports no change to products, sales, or profit, so this does not alter the company's outlook.
This changes who helps oversee AbbVie, not what the company sells. The filing reports no change to products, sales, or profit. The new director will receive board pay, but the filing ties the appointment to no business result.
Follow AbbVie Inc. (ABBV) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ABBV